ESR1 mutant breast cancers show elevated basal cytokeratins and immune activation.
Li Z, McGinn O, Wu Y, Bahreini A, Priedigkeit NM, Ding K, Onkar S, Lampenfeld C, Sartorius CA, Miller L, Rosenzweig M, Cohen O, Wagle N, Richer JK, Muller WJ, Buluwela L, Ali S, Bruno TC, Vignali DAA, Fang Y, Zhu L, Tseng GC, Gertz J, Atkinson JM, Lee AV, Oesterreich S.
Li Z, et al. Among authors: onkar s.
Nat Commun. 2022 Apr 19;13(1):2011. doi: 10.1038/s41467-022-29498-9.
Nat Commun. 2022.
PMID: 35440136
Free PMC article.